Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)

SHA:600329 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,455	2,944	2,125	2,883	2,283	1,987
Short-Term Investments	-	-	61.7	40.61	109.64	-
Cash & Short-Term Investments	1,455	2,944	2,187	2,923	2,393	1,987
Cash Growth	-40.81%	34.64%	-25.19%	22.16%	20.40%	30.49%
Accounts Receivable	1,689	1,316	2,653	2,725	1,971	1,971
Other Receivables	8.39	8.53	34.1	60.77	40.73	36.63
Receivables	1,697	1,325	2,687	2,785	2,011	2,007
Inventory	1,205	1,286	1,567	1,429	1,525	1,488
Other Current Assets	1,339	1,053	111.07	107.5	495.77	121.13
Total Current Assets	5,696	6,608	6,552	7,245	6,425	5,604
Property, Plant & Equipment	1,379	1,393	1,442	1,465	1,486	1,460
Long-Term Investments	1,316	1,294	882.67	801.46	740.74	803.85
Goodwill	12.3	12.3	65.91	84.69	-	-
Other Intangible Assets	290.69	295.29	317.75	281.13	198.19	202.51
Long-Term Deferred Tax Assets	339.49	314.4	265.99	208.35	154.6	165.48
Long-Term Deferred Charges	66.46	66.07	18.3	17.54	4.72	8.81
Other Long-Term Assets	2,068	785.43	686.29	53.77	57.51	39.47
Total Assets	11,168	10,769	10,230	10,157	9,067	8,283
Accounts Payable	264.27	284.51	1,126	1,406	1,242	902.25
Accrued Expenses	267.91	270.09	1,493	1,170	679.77	709.16
Short-Term Debt	72.43	21.65	81.8	101.64	-	-
Current Portion of Long-Term Debt	2.12	1.33	-	-	30	-
Current Portion of Leases	-	-	3.56	4.1	1.6	1
Current Income Taxes Payable	194.03	335.48	76.68	93.28	9.53	10.49
Current Unearned Revenue	94.76	123.14	145.66	219.07	215.61	246.67
Other Current Liabilities	1,952	1,782	305.66	339.37	254.89	294.27
Total Current Liabilities	2,847	2,818	3,233	3,333	2,434	2,164
Long-Term Debt	-	-	251.03	161.3	10	40
Long-Term Leases	4.33	5.6	2.74	0.87	1.57	1.71
Long-Term Unearned Revenue	54.91	55.14	57.14	59.88	59.15	63.35
Long-Term Deferred Tax Liabilities	5.73	6.04	7.33	8.82	4.21	3.8
Other Long-Term Liabilities	34.07	34.07	33.69	40.73	44.42	60.78
Total Liabilities	2,946	2,919	3,585	3,605	2,553	2,333
Common Stock	770.09	770.09	770.16	773.44	773.44	773.64
Additional Paid-In Capital	974.79	974.79	975.21	1,048	1,374	1,365
Retained Earnings	6,446	6,072	4,828	4,700	4,218	3,681
Treasury Stock	-	-	-7.04	-29.75	-32.03	-34.78
Comprehensive Income & Other	26.82	26.93	34.34	29.53	30.62	23.19
Total Common Equity	8,218	7,844	6,601	6,521	6,364	5,808
Minority Interest	3.88	6.34	44.55	30.49	149.35	141.49
Shareholders' Equity	8,222	7,850	6,645	6,552	6,514	5,950
Total Liabilities & Equity	11,168	10,769	10,230	10,157	9,067	8,283
Total Debt	78.88	28.59	339.14	267.91	43.17	42.71
Net Cash (Debt)	1,376	2,916	1,848	2,655	2,350	1,945
Net Cash Growth	-24.80%	57.80%	-30.41%	13.01%	20.83%	31.46%
Net Cash Per Share	1.79	3.78	2.40	3.42	3.05	2.53
Filing Date Shares Outstanding	763.77	770.09	770.16	773.44	773.44	773.64
Total Common Shares Outstanding	763.77	770.09	770.16	773.44	773.44	773.64
Working Capital	2,849	3,790	3,319	3,912	3,991	3,440
Book Value Per Share	10.76	10.19	8.57	8.43	8.23	7.51
Tangible Book Value	7,915	7,536	6,217	6,156	6,166	5,606
Tangible Book Value Per Share	10.36	9.79	8.07	7.96	7.97	7.25
Buildings	-	-	1,338	1,337	1,323	1,341
Machinery	-	-	1,107	1,087	1,028	978.12
Construction In Progress	-	-	386.46	333.85	331.62	285.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.